Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene
A recent patent fight between the liquid biopsy companies Natera and Inivata is only the…
A recent patent fight between the liquid biopsy companies Natera and Inivata is only the…
The major research funder CRUK and two of the biotech companies it works with have…
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
A colossal deal struck last month between Germany’s Merck KGaA and UK-based Artios Pharma is…
The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody…
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
An initially promising drug has failed to show benefits in a phase II trial for…
Swedish biotech Oncopeptides has raised €133M (SEK 1.4B) by issuing new company shares, surpassing expectations…
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced…
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…